Literature DB >> 22304675

Mouse models for studying genetic influences on factors determining smoking cessation success in humans.

F Scott Hall1, Athina Markou, Edward D Levin, George R Uhl.   

Abstract

Humans differ in their ability to quit using addictive substances, including nicotine, the major psychoactive ingredient in tobacco. For tobacco smoking, a substantial body of evidence, largely derived from twin studies, indicates that approximately half of these individual differences in ability to quit are heritable genetic influences that likely overlap with those for other addictive substances. Both twin and molecular genetic studies support overlapping influences on nicotine addiction vulnerability and smoking cessation success, although there is little formal analysis of the twin data that support this important point. None of the current datasets provides clarity concerning which heritable factors might provide robust dimensions around which individuals differ in ability to quit smoking. One approach to this problem is to test mice with genetic variations in genes that contain human variants that alter quit success. This review considers which features of quit success should be included in a comprehensive approach to elucidate the genetics of quit success, and how those features may be modeled in mice.
© 2012 New York Academy of Sciences.

Entities:  

Mesh:

Year:  2012        PMID: 22304675      PMCID: PMC4133119          DOI: 10.1111/j.1749-6632.2011.06415.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  319 in total

1.  Association of promoter variants in the alpha7 nicotinic acetylcholine receptor subunit gene with an inhibitory deficit found in schizophrenia.

Authors:  Sherry Leonard; Judith Gault; Jan Hopkins; Judith Logel; Ruby Vianzon; Margaret Short; Carla Drebing; Ralph Berger; Diana Venn; Pinkhas Sirota; Gary Zerbe; Ann Olincy; Randal G Ross; Lawrence E Adler; Robert Freedman
Journal:  Arch Gen Psychiatry       Date:  2002-12

2.  Nicotine improves cognitive deficits of dopamine transporter knockout mice without long-term tolerance.

Authors:  Stéphanie Weiss; Marika Nosten-Bertrand; J Michael McIntosh; Bruno Giros; Marie-Pascale Martres
Journal:  Neuropsychopharmacology       Date:  2007-03-21       Impact factor: 7.853

Review 3.  ADHD and smoking: from genes to brain to behavior.

Authors:  Francis Joseph McClernon; Scott Haden Kollins
Journal:  Ann N Y Acad Sci       Date:  2008-10       Impact factor: 5.691

4.  DAT genotype modulates brain and behavioral responses elicited by cigarette cues.

Authors:  Teresa R Franklin; Falk W Lohoff; Ze Wang; Nathan Sciortino; Derek Harper; Yin Li; Will Jens; Jeffrey Cruz; Kyle Kampman; Ron Ehrman; Wade Berrettini; John A Detre; Charles P O'Brien; Anna Rose Childress
Journal:  Neuropsychopharmacology       Date:  2008-08-13       Impact factor: 7.853

5.  Hippocampal alpha4beta2 nicotinic acetylcholine receptor involvement in the enhancing effect of acute nicotine on contextual fear conditioning.

Authors:  Jennifer A Davis; Justin W Kenney; Thomas J Gould
Journal:  J Neurosci       Date:  2007-10-03       Impact factor: 6.167

6.  Dopamine enables in vivo synaptic plasticity associated with the addictive drug nicotine.

Authors:  Jianrong Tang; John A Dani
Journal:  Neuron       Date:  2009-09-10       Impact factor: 17.173

7.  Genome-wide association for methamphetamine dependence: convergent results from 2 samples.

Authors:  George R Uhl; Tomas Drgon; Qing-Rong Liu; Catherine Johnson; Donna Walther; Tokutaro Komiyama; Mutsuo Harano; Yoshimoto Sekine; Toshiya Inada; Norio Ozaki; Masaomi Iyo; Nakao Iwata; Mitsuhiko Yamada; Ichiro Sora; Chih-Ken Chen; Hsing-Cheng Liu; Hiroshi Ujike; Shih-Ku Lin
Journal:  Arch Gen Psychiatry       Date:  2008-03

8.  Bupropion dose-dependently reverses nicotine withdrawal deficits in contextual fear conditioning.

Authors:  George S Portugal; Thomas J Gould
Journal:  Pharmacol Biochem Behav       Date:  2007-08-23       Impact factor: 3.533

9.  Decreased anxiety-like behavior in beta3 nicotinic receptor subunit knockout mice.

Authors:  T K Booker; Christopher M Butt; Jeanne M Wehner; Stephen F Heinemann; Allan C Collins
Journal:  Pharmacol Biochem Behav       Date:  2007-04-21       Impact factor: 3.533

10.  Conditional knockout of NMDA receptors in dopamine neurons prevents nicotine-conditioned place preference.

Authors:  Lei Phillip Wang; Fei Li; Xiaoming Shen; Joe Z Tsien
Journal:  PLoS One       Date:  2010-01-07       Impact factor: 3.240

View more
  6 in total

Review 1.  Negative affective states and cognitive impairments in nicotine dependence.

Authors:  F Scott Hall; Andre Der-Avakian; Thomas J Gould; Athina Markou; Mohammed Shoaib; Jared W Young
Journal:  Neurosci Biobehav Rev       Date:  2015-06-06       Impact factor: 8.989

2.  Serotonergic involvement in the amelioration of behavioral abnormalities in dopamine transporter knockout mice by nicotine.

Authors:  Osamu Uchiumi; Yoshiyuki Kasahara; Asami Fukui; F Scott Hall; George R Uhl; Ichiro Sora
Journal:  Neuropharmacology       Date:  2012-07-15       Impact factor: 5.250

3.  Strain-specific altered nicotine metabolism in 3,3'-diindolylmethane (DIM) exposed mice.

Authors:  A Joseph Bloom; Pramod Upadhyaya; Evan D Kharasch
Journal:  Biopharm Drug Dispos       Date:  2019-05-20       Impact factor: 1.627

4.  Nine generations of selection for high and low nicotine intake in outbred Sprague-Dawley rats.

Authors:  Tanseli Nesil; Lutfiye Kanit; Ming D Li; Sakire Pogun
Journal:  Behav Genet       Date:  2013-08-04       Impact factor: 2.805

Review 5.  The Role of Cell Adhesion Molecule Genes Regulating Neuroplasticity in Addiction.

Authors:  Dawn E Muskiewicz; George R Uhl; F Scott Hall
Journal:  Neural Plast       Date:  2018-02-20       Impact factor: 3.599

6.  Aerobic and concentration training and allele 7 in the dopamine receptor D4 (D4DR) gene increase chances of smoking cessation in young Polish women.

Authors:  Tomasz Podgórski; Grażyna Szmyt; Agnieszka Szmyt; Joanna Gronek; Roman Celka; Piotr Gronek
Journal:  Arch Med Sci       Date:  2017-12-19       Impact factor: 3.318

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.